{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T09:37:17Z","timestamp":1768124237191,"version":"3.49.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T00:00:00Z","timestamp":1543968000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81373167"],"award-info":[{"award-number":["81373167"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91542110"],"award-info":[{"award-number":["91542110"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.biopha.2018.12.025","type":"journal-article","created":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T14:04:58Z","timestamp":1544623498000},"page":"692-699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Glycyrrhizin alleviates Con A-induced hepatitis by differentially regulating the production of IL-17 and IL-25"],"prefix":"10.1016","volume":"110","author":[{"given":"Yuanyue","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyao","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyuan","family":"Fei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feili","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.12.025_bib0005","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/gutjnl-2015-311247","article-title":"PGAM5-mediated programmed necrosis of hepatocytes drives acute liver injury","volume":"66","author":"He","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2018.12.025_bib0010","doi-asserted-by":"crossref","first-page":"85","DOI":"10.5625\/lar.2018.34.3.85","article-title":"Mouse models for hepatitis B virus research","volume":"34","author":"Hwang","year":"2018","journal-title":"Lab Anim. Res."},{"key":"10.1016\/j.biopha.2018.12.025_bib0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/0023677215572841","article-title":"The concanavalin A model of acute hepatitis in mice","volume":"49","author":"Heymann","year":"2015","journal-title":"Lab Anim."},{"issue":"2125-2135","key":"10.1016\/j.biopha.2018.12.025_bib0020","first-page":"e2121","article-title":"Myeloid STAT3 inhibits T cell-mediated hepatitis by regulating T helper 1 cytokine and interleukin-17 production","volume":"137","author":"Lafdil","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2018.12.025_bib0025","doi-asserted-by":"crossref","first-page":"7473","DOI":"10.4049\/jimmunol.181.11.7473","article-title":"Requirement of IL-17RA in Con A induced hepatitis and negative regulation of IL-17 production in mouse T cells","author":"Nagata","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2018.12.025_bib0030","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/icb.2011.59","article-title":"Critical role of interleukin-17\/interleukin-17 receptor axis in mediating Con A-induced hepatitis","volume":"90","author":"Yan","year":"2012","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.biopha.2018.12.025_bib0035","doi-asserted-by":"crossref","first-page":"669","DOI":"10.4049\/jimmunol.1600977","article-title":"IL-17C\/IL-17RE augments T cell function in autoimmune hepatitis","volume":"198","author":"Huang","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2018.12.025_bib0040","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1084\/jem.20061675","article-title":"Interleukin 25 promotes the initiation of proallergic type 2 responses","volume":"204","author":"Angkasekwinai","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2018.12.025_bib0045","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.cyto.2008.07.017","article-title":"An overview of IL-17 function and signaling","volume":"43","author":"Gaffen","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.biopha.2018.12.025_bib0050","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1182\/blood-2002-09-2817","article-title":"Mast cells produce interleukin-25 upon Fc epsilon RI-mediated activation","volume":"101","author":"Ikeda","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2018.12.025_bib0055","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1397249","article-title":"IL-25 dampens the growth of human germinal center-derived B-cell non Hodgkin Lymphoma by curtailing neoangiogenesis","volume":"7","author":"Ferretti","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.biopha.2018.12.025_bib0060","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4049\/jimmunol.169.1.443","article-title":"New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25","volume":"169","author":"Hurst","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2018.12.025_bib0065","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1111\/febs.12801","article-title":"Glycyrrhizin inhibits the inflammatory response in mouse mammary epithelial cells and a mouse mastitis model","volume":"281","author":"Fu","year":"2014","journal-title":"FEBS J."},{"key":"10.1016\/j.biopha.2018.12.025_bib0070","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0973-6883(12)60079-6","article-title":"Treatment of chronic hepatitis due to hepatitis C virus (CH-C) in India: a randomized controlled trial comparing daily interferon-alfa-2b and ribavirin with daily interferon-alfa-2b and glycyrrhizin-A multicenter study","volume":"2","author":"Acharya","year":"2012","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.biopha.2018.12.025_bib0075","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1007\/s00535-003-1179-7","article-title":"Glycyrrhizin enhances interleukin-10 production by liver dendritic cells in mice with hepatitis","volume":"38","author":"Abe","year":"2003","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.biopha.2018.12.025_bib0080","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00011-009-0024-8","article-title":"Hepatic protection by glycyrrhizin and inhibition of iNOS expression in concanavalin A-induced liver injury in mice","volume":"58","author":"Tsuruoka","year":"2009","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.biopha.2018.12.025_bib0085","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s12026-017-8894-2","article-title":"Glycyrrhizin ameliorates experimental colitis through attenuating interleukin-17-producing T cell responses via regulating antigen-presenting cells","volume":"65","author":"Chen","year":"2017","journal-title":"Immunol. Res."},{"key":"10.1016\/j.biopha.2018.12.025_bib0090","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1172\/JCI115836","article-title":"A T cell-dependent experimental liver injury in mice inducible by concanavalin A","volume":"90","author":"Tiegs","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2018.12.025_bib0095","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.brainres.2014.07.002","article-title":"Glycyrrhizin protects brain against ischemia-reperfusion injury in mice through HMGB1-TLR4-IL-17A signaling pathway","volume":"1582","author":"Zhang","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2018.12.025_bib0100","first-page":"16266","article-title":"Glycyrrhizin combined with acitretin improve clinical symptom of psoriasis via reducing Th17 cell differentiation and related serum cytokine concentrations","volume":"8","author":"Wu","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.biopha.2018.12.025_bib0105","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jhep.2006.05.015","article-title":"Biochemical and histological effects of 26 weeks of glycyrrhizin treatment in chronic hepatitis C: a randomized phase II trial","volume":"45","author":"Orlent","year":"2006","journal-title":"J. Hepatol."},{"issue":"Suppl. 2","key":"10.1016\/j.biopha.2018.12.025_bib0110","first-page":"S287","article-title":"Glycyrrhizin injection therapy prevents hepatocellular carcinogenesis in patients with interferon-resistant active chronic hepatitis C","volume":"37","author":"Ikeda","year":"2007","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.biopha.2018.12.025_bib0115","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1189\/jlb.0306173","article-title":"Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice","volume":"81","author":"Sitia","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.biopha.2018.12.025_bib0120","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1479-5876-9-112","article-title":"Glycyrrhizin as antiviral agent against Hepatitis C Virus","volume":"9","author":"Ashfaq","year":"2011","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.biopha.2018.12.025_bib0125","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1007\/s10620-011-1789-5","article-title":"Efficacy of intravenous glycyrrhizin in the early stage of acute onset autoimmune hepatitis","volume":"56","author":"Yasui","year":"2011","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.biopha.2018.12.025_bib0130","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.chembiol.2007.03.007","article-title":"Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities","volume":"14","author":"Mollica","year":"2007","journal-title":"Chem. Biol."},{"key":"10.1016\/j.biopha.2018.12.025_bib0135","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1097\/TP.0b013e318293b7e1","article-title":"Hmgb1-TLR4-IL-23-IL-17A axis promote ischemia-reperfusion injury in a cardiac transplantation model","volume":"95","author":"Zhu","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.biopha.2018.12.025_bib0140","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S1074-7613(01)00243-6","article-title":"IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo","volume":"15","author":"Fort","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2018.12.025_bib0145","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1084\/jem.20070406","article-title":"IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells","volume":"204","author":"Wang","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2018.12.025_bib0150","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1128\/IAI.00646-13","article-title":"Interleukin-25 (IL-25) promotes efficient protective immunity against Trichinella spiralis infection by enhancing the antigen-specific IL-9 response","volume":"81","author":"Angkasekwinai","year":"2013","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biopha.2018.12.025_bib0155","doi-asserted-by":"crossref","first-page":"G313","DOI":"10.1152\/ajpgi.00097.2016","article-title":"Ablation of interaction between IL-33 and ST2+ regulatory T cells increases immune cell-mediated hepatitis and activated NK cell liver infiltration","volume":"311","author":"Noel","year":"2016","journal-title":"Am. J. Physiol. Gastrointest Liver Physiol."},{"key":"10.1016\/j.biopha.2018.12.025_bib0160","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/cei.12917","article-title":"Tumour-activated liver stromal cells regulate myeloid-derived suppressor cells accumulation in the liver","volume":"188","author":"Zhang","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.biopha.2018.12.025_bib0165","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1002\/hep.30095","article-title":"The immunobiology of RANKL and myeloid derived suppressor cell activation in IgG4-related sclerosing cholangitis","volume":"68","author":"Lian","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2018.12.025_bib0170","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1002\/hep.26446","article-title":"IL-25 prevents and cures fulminant hepatitis in mice through a myeloid-derived suppressor cell-dependent mechanism","volume":"58","author":"Sarra","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2018.12.025_bib0175","doi-asserted-by":"crossref","DOI":"10.1111\/eci.12989","article-title":"Neutrophils as myeloid-derived suppressor cells","author":"Aarts","year":"2018","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.biopha.2018.12.025_bib0180","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2018.12.025_bib0185","first-page":"1","article-title":"Myeloid-derived suppressor cells in infection: a general overview","author":"Medina","year":"2018","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.biopha.2018.12.025_bib0190","doi-asserted-by":"crossref","first-page":"507","DOI":"10.4049\/jimmunol.1800180","article-title":"Myeloid-derived suppressor cells contribute to susceptibility to trypanosoma congolense infection by suppressing CD4(+) T cell proliferation and IFN-gamma production","volume":"201","author":"Onyilagha","year":"2018","journal-title":"J. Immunol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218368616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218368616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T21:18:23Z","timestamp":1764105503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218368616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":38,"alternative-id":["S0753332218368616"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.12.025","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycyrrhizin alleviates Con A-induced hepatitis by differentially regulating the production of IL-17 and IL-25","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.12.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}